STOCK TITAN

Critical Metals reprices 180K options to $5.31

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Critical Metals Corp. reported the disposition to the issuer of 180,000 options and a grant of 180,000 options to President of European Operations Dietrich Wanke in a one-time repricing effective November 12, 2026. The exercise price changed from $12.88 to $5.31 per share. The options vest, if at all, in three one-third tranches when VWAP thresholds of $6.65, $8.30 and $10.37 are achieved through October 31, 2026, October 31, 2027 and October 31, 2028, respectively. Any tranche that has not vested by its applicable deadline automatically terminates.

Insider Wanke Dietrich
Role Pres. of Euro. Ops.
Type Security Shares Price Value
Disposition Option (Right to Buy) F1, F2 180,000 -- --
Grant/Award Option (Right to Buy) F1, F2 180,000 -- --
Holdings After Transaction: Option (Right to Buy) — 0 options (Direct)
Footnotes (2)
  1. F1. The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on November 12, 2026 (the "Effective Date"). The Option Repricing applies to options with exercise prices equal to $12.88 per share (the "Original Exercise Price") held by the reporting person as of the Effective Date. Each stock option at the Original Exercise Price was amended such that the exercise price is now $5.31.
  2. F2. Represents a right to receive an option for one ordinary share of the Issuer, par value $0.001 per share ("Ordinary Shares"). The Ordinary Shares underlying the options vest, if at all, based on the achievement of a certain volume weighted average price per Ordinary Share for any trailing twenty (20) consecutive trading days ("VWAP") beginning on or after November 28, 2025, as determined, approved and certified by the Compensation Committee of the Board of Directors. Pursuant to the Option Repricing, the options will vest upon satisfaction of the following thresholds: 1/3rd upon the achievement of a $6.65 VWAP through October 31, 2026, 1/3rd upon the achievement of a $8.30 VWAP through October 31, 2027, and 1/3rd upon the achievement of a $10.37 VWAP through October 31, 2028. Any tranche of options that has not vested by the last day of the applicable period shall automatically terminate.
Options disposed to issuer 180,000 options November 12, 2026 repricing
Options granted 180,000 options November 12, 2026 repricing
Original exercise price $12.88 per share Price before the repricing
Repriced exercise price $5.31 per share Price after the repricing
VWAP vesting threshold $6.65 One-third tranche; through October 31, 2026
VWAP vesting threshold $8.30 One-third tranche; through October 31, 2027
VWAP vesting threshold $10.37 One-third tranche; through October 31, 2028
stock option repricing financial
"one-time stock option repricing effective on November 12, 2026"
exercise price financial
"the exercise price is now $5.31"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
volume weighted average price financial
"volume weighted average price for any trailing twenty (20) consecutive trading days"
The volume weighted average price (VWAP) is a way to measure the average price of a security, such as a stock, over a specific period, taking into account how many units were traded at each price. It’s similar to calculating the average cost of items bought when some are more frequently purchased than others. Investors use VWAP to assess whether a security is being bought or sold at a fair price during trading.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How do CRML's repriced options vest?

The options vest, if at all, based on a VWAP measured over any trailing 20 consecutive trading days beginning on or after November 28, 2025, as determined, approved and certified by the Board's Compensation Committee. One-third vests at a $6.65 VWAP through October 31, 2026, one-third at $8.30 through October 31, 2027, and one-third at $10.37 through October 31, 2028. Any tranche not vested by its applicable deadline automatically terminates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Wanke Dietrich

(Last)(First)(Middle)
251 LITTLE FALLS DRIVE

(Street)
WILMINGTON DELAWARE 19808

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Critical Metals Corp. [ CRML ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Pres. of Euro. Ops.
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option (Right to Buy)$5.31(1)11/12/2026D180,000(1) (2) (2)Ordinary Shares180,000(2)0(2)D
Option (Right to Buy)$5.31(1)11/12/2026A180,000(1) (2) (2)Ordinary Shares180,000(2)0(2)D
Explanation of Responses:
1. The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on November 12, 2026 (the "Effective Date"). The Option Repricing applies to options with exercise prices equal to $12.88 per share (the "Original Exercise Price") held by the reporting person as of the Effective Date. Each stock option at the Original Exercise Price was amended such that the exercise price is now $5.31.
2. Represents a right to receive an option for one ordinary share of the Issuer, par value $0.001 per share ("Ordinary Shares"). The Ordinary Shares underlying the options vest, if at all, based on the achievement of a certain volume weighted average price per Ordinary Share for any trailing twenty (20) consecutive trading days ("VWAP") beginning on or after November 28, 2025, as determined, approved and certified by the Compensation Committee of the Board of Directors. Pursuant to the Option Repricing, the options will vest upon satisfaction of the following thresholds: 1/3rd upon the achievement of a $6.65 VWAP through October 31, 2026, 1/3rd upon the achievement of a $8.30 VWAP through October 31, 2027, and 1/3rd upon the achievement of a $10.37 VWAP through October 31, 2028. Any tranche of options that has not vested by the last day of the applicable period shall automatically terminate.
/s/ John Thomas, Attorney-in-Fact/s/11/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading